JMB Capital Partners restructured with 23andMe Holding Co. as part of a restructuring on not available.
Deal value was 3800000000 (source: AI Estimation) Sector: Biotechnology; Location: USA.
On the seller side, not available advised, led by Christopher Hopkins, Jeffrey Marell, John Carlin, John Kennedy, Lawrence Witdorchic, Paul Basta, Robert Holo, Sung Pak, William Clareman.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Paul, Weiss advises 23andMe in voluntary chapter 11 proceedings | The Sponsor - The Sponsor
